The latest closing stock price for Apogee Therapeutics as of May 30, 2025 is 36.64.
An investor who bought $1,000 worth of Apogee Therapeutics stock at the IPO in 2023 would have $1,155 today, roughly 1 times their original investment - a 46.81% compound annual growth rate over 2 years.
The all-time high Apogee Therapeutics stock closing price was 69.80 on March 13, 2024.
The Apogee Therapeutics 52-week high stock price is 63.50, which is 73.3% above the current share price.
The Apogee Therapeutics 52-week low stock price is 26.20, which is 28.5% below the current share price.
The average Apogee Therapeutics stock price for the last 52 weeks is 44.02.
An investor who bought $1,000 worth of Apogee Therapeutics stock at the IPO in 2023 would have $1,155 today, roughly 1 times their original investment - a 46.81% compound annual growth rate over 2 years.
The all-time high Apogee Therapeutics stock closing price was 69.80 on March 13, 2024.
The Apogee Therapeutics 52-week high stock price is 63.50, which is 73.3% above the current share price.
The Apogee Therapeutics 52-week low stock price is 26.20, which is 28.5% below the current share price.
The average Apogee Therapeutics stock price for the last 52 weeks is 44.02.